A new trading day began on Friday, with Cabaletta Bio Inc (NASDAQ: CABA) stock price down -6.21% from the previous day of trading, before settling in for the closing price of $1.45. CABA’s price has ranged from $0.99 to $6.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.35% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -4.70%. With a float of $83.21 million, this company’s outstanding shares have now reached $91.45 million.
In an organization with 161 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cabaletta Bio Inc (CABA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cabaletta Bio Inc is 9.03%, while institutional ownership is 46.06%.
Cabaletta Bio Inc (CABA) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.62 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.39% during the next five years compared to -20.35% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Here are Cabaletta Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.71, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.96 million. That was inferior than the volume of 1.54 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.43%.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 23.13%, which indicates a significant increase from 2.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0975 in the past 14 days, which was lower than the 0.1425 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7424, while its 200-day Moving Average is $2.1613. However, in the short run, Cabaletta Bio Inc’s stock first resistance to watch stands at $1.4233. Second resistance stands at $1.4867. The third major resistance level sits at $1.5233. If the price goes on to break the first support level at $1.3233, it is likely to go to the next support level at $1.2867. The third support level lies at $1.2233 if the price breaches the second support level.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
With a market capitalization of 124.39 million, the company has a total of 50,743K Shares Outstanding. Currently, annual sales are 0 K while annual income is -115,860 K. The company’s previous quarter sales were 0 K while its latest quarter income was -35,940 K.
